Research ArticleImmunotherapy

PD-1– and CTLA-4–Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses

See allHide authors and affiliations

Science Translational Medicine  11 Dec 2013:
Vol. 5, Issue 215, pp. 215ra172
DOI: 10.1126/scitranslmed.3006597

Log in to view Figures & Data

Log in through your institution

Log in through your institution